# Renal-First Lupus: Avoid Diagnostic Shortcuts

Persistent kidney abnormalities merit explanation, even when the usual systemic clues are absent.

![Infographic: Renal-First Lupus: Avoid Diagnostic Shortcuts](https://urinenephrology.org/visual-reference/images/supplemental-renal-first-lupus.png?v=20261003c)

## Take persistent urine findings seriously

Repeated microscopic hematuria, proteinuria, or worsening kidney function deserves a structured evaluation. Confirm collection quality, exclude common causes, and follow the trajectory rather than dismissing a persistent signal.

## Serology informs probability

ANA, anti-dsDNA, and complement help assess autoimmune disease, but no single test should be interpreted outside the clinical and pathological context. Classification criteria and bedside diagnosis serve different purposes.

## Quantify and trend protein

Albumin and total protein measurements answer related but different questions. Repeat unexpected results and use consistent units and methods when evaluating progression or treatment response.

## Let persistent renal findings drive evaluation

Quantified proteinuria, active sediment, or otherwise unexplained loss of kidney function can justify a biopsy discussion even when anti-dsDNA or complement is not striking. Biopsy distinguishes activity, chronic damage, and competing lesions; it also prevents serologic reassurance from delaying renal assessment.

## Match treatment to disease

Treatment depends on histologic class, activity, chronic damage, kidney function, comorbidities, and goals. Kidney failure changes eligibility and risk; specialist review is essential.

## Do not turn subgroup results into exclusions

When selecting an add-on therapy, use guideline recommendations, labeling, renal function, and the actual trial population. An exploratory proteinuria subgroup is not a universal contraindication, nor proof that another active drug is superior. Reassess the clinical and urine response before escalating for presumed treatment failure.

## Supporting evidence

- [Supporting guideline or source](https://kdigo.org/wp-content/uploads/2024/01/KDIGO-2024-Lupus-Nephritis-Guideline.pdf)

## Source lessons

- [lupus nephritis renal first](https://urinenephrology.org/case-reports/lupus-nephritis-renal-first.html)

Read alongside the full lessons; the findings and decisions shown here require the stated clinical context.